<div id="readability-page-1"><p>New York State Common Retirement Fund cut its stake in  Cushman &amp; Wakefield PLC (NYSE:CWK - Free Report) by 86.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor  owned 190,633 shares of the company's stock after selling 1,259,558 shares during the period. New York State Common Retirement Fund owned about 0.08% of Cushman &amp; Wakefield worth $2,110,000 at the end of the most recent reporting period.</p><ul><li>Real Estate Stock Signals a Boom in Manufacturing Activity</li></ul><p>Several other hedge funds and other institutional investors have also modified their holdings of CWK. Vaughan Nelson Investment Management L.P. grew its position in  Cushman &amp; Wakefield by 46.2% in the second quarter. Vaughan Nelson Investment Management L.P. now owns 12,156,514 shares of the company's stock valued at $134,573,000 after acquiring an additional 3,842,859 shares during the period.  Dimensional Fund Advisors LP lifted its holdings in shares of  Cushman &amp; Wakefield by 4.1% during the first quarter. Dimensional Fund Advisors LP now owns 12,064,891 shares of the company's stock valued at $123,300,000 after acquiring an additional 478,484 shares during the period.  Geode Capital Management LLC boosted its stake in shares of  Cushman &amp; Wakefield by 1.1% in the 2nd quarter. Geode Capital Management LLC now owns 5,925,513 shares of the company's stock valued at $65,603,000 after purchasing an additional 62,582 shares in the last quarter.  Channing Capital Management LLC boosted its stake in shares of  Cushman &amp; Wakefield by 13.8% in the 1st quarter. Channing Capital Management LLC now owns 5,369,263 shares of the company's stock valued at $54,874,000 after purchasing an additional 649,705 shares in the last quarter.  Finally, Ameriprise Financial Inc. grew its holdings in shares of  Cushman &amp; Wakefield by 1.8% in the 1st quarter. Ameriprise Financial Inc. now owns 4,022,204 shares of the company's stock worth $41,107,000 after purchasing an additional 70,899 shares during the last quarter. Institutional investors own  95.56% of the company's stock. </p><div><p><span></span><span>Get <strong>Cushman &amp; Wakefield</strong> alerts:</span></p></div><h2>Cushman &amp; Wakefield Stock Down 3.6%</h2><p>NYSE CWK opened at $15.21 on Tuesday. The stock has a market capitalization of $3.52 billion, a P/E ratio of 15.84 and a beta of 1.45. Cushman &amp; Wakefield PLC has a 52 week low of $7.64 and a 52 week high of $17.33. The company has a debt-to-equity ratio of 1.39, a quick ratio of 1.07 and a current ratio of 1.07. The stock has a fifty day moving average of $15.86 and a 200-day moving average of $14.00. </p><ul><li>Renewed Analyst Sentiment for CBRE Group Stock: Buy the Dip?</li></ul><p>Cushman &amp; Wakefield (NYSE:CWK - Get Free Report) last posted its quarterly earnings results on Thursday, October 30th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.01. The business had revenue of $2.61 billion for the quarter, compared to analysts' expectations of $2.51 billion. Cushman &amp; Wakefield had a return on equity of 14.69% and a net margin of 2.23%.The firm's quarterly revenue was up 11.2% compared to the same quarter last year. During the same quarter last year, the business earned $0.23 earnings per share. Cushman &amp; Wakefield has set its FY 2025 guidance at 1.180-1.230 EPS.  On average, equities research analysts forecast that  Cushman &amp; Wakefield PLC will post 1.2 EPS for the current year. </p><h2>Analyst Upgrades and Downgrades</h2><p>Several equities analysts recently issued reports on CWK shares. Citizens Jmp lifted their price target on shares of Cushman &amp; Wakefield from $16.00 to $19.00 and gave the company a &#34;market outperform&#34; rating in a report on Monday, November 3rd. UBS Group raised their price objective on shares of Cushman &amp; Wakefield from $12.00 to $17.00 and gave the stock a &#34;neutral&#34; rating in a report on Friday, October 10th. Barclays started coverage on Cushman &amp; Wakefield in a report on Tuesday, December 2nd. They issued an &#34;equal weight&#34; rating and a $18.00 target price on the stock. JMP Securities  set a $19.00 price target on Cushman &amp; Wakefield in a research report on Monday, November 3rd. Finally, Weiss Ratings  reaffirmed a &#34;hold (c)&#34; rating on shares of Cushman &amp; Wakefield in a report on Wednesday, October 8th. Five investment analysts have rated the stock with a Buy rating and six have issued  a Hold rating to the stock. According to MarketBeat, Cushman &amp; Wakefield presently has a consensus rating of &#34;Hold&#34; and a consensus target price of $17.44.</p><p><b>View Our Latest Research Report on CWK</b></p><h2>About Cushman &amp; Wakefield</h2> (Free Report)<p>Cushman &amp; Wakefield Plc engages in the provision of commercial real estate services. It operates through the following geographical segments: Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific (APAC). The Americas segment consists of operations located in the United States, Canada and key markets in Latin America.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Cushman &amp; Wakefield</li><li>Why is the Ex-Dividend Date Significant to Investors?</li><li>What Dollar Tree’s Surge and Home Depot’s Slide Say About Consumer Health</li><li>There Are Different Types of Stock To Invest In</li><li>3 Stocks Most Likely to Split in 2026</li><li>How to Calculate Options Profits</li><li>ChargePoint's Comeback Story: Why This EV Stock Is Charging Up Again</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNXSw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNXSw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Cushman &amp; Wakefield Right Now?</h2><p>Before you consider Cushman &amp; Wakefield, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cushman &amp; Wakefield wasn't on the list.</p><p>While Cushman &amp; Wakefield currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>New York State Common Retirement Fund sold 1,259,558 shares of Cushman & Wakefield, reducing its stake by 86.9% in Q2. The stock opened at $15.21, down 3.6%. Analysts have mixed ratings, with a consensus target price of $17.44. Cushman & Wakefield reported Q3 earnings of $0.29 per share, beating estimates, with revenue up 11.2% year-over-year.</p>

New York State Common Retirement Fund Sells 1,259,558 Shares of Cushman & Wakefield PLC $CWK